Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review. Yan QL, Zhang LY, Niu WS, Shi JJ, et al. Allergy Asthma Proc 2026;47:e24-e35.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan QL, Zhang LY, Niu WS, Shi JJ, et al. Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review. Allergy Asthma Proc 2026;47:e24-e35.
PMID: 42050841